279.89MMarket Cap-1.86P/E (TTM)
2.000High1.680Low906.80KVolume1.680Open1.705Pre Close1.45MTurnover1.67%Turnover RatioLossP/E (Static)145.02MShares3.78052wk High2.46P/B104.73MFloat Cap0.91252wk Low--Dividend TTM54.27MShs Float22.810Historical High--Div YieldTTM18.77%Amplitude0.912Historical Low1.602Avg Price1Lot Size
Lanvin Group Stock Forum
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Lanvin Group Holdings Limited (NYSE: LANV, the "Company" or "Lanvin Group"), a global luxury fashion group, today announced that it will hold its annual general meeting of the shareholders (the "AGM") virtually through a live webcast and teleconference on December 11, 2024 at 9:00 AM EST. No proposals will be submitted for shareholder approval at the AGM. Instead, the AGM will serve as an open forum for shareholders to discuss Compa...
Lanvin Group Posts Revenue of €171 million in H1 2024
Lanvin Group (NYSE: LANV) reported H1 2024 revenue of €171 million, a 20% decrease from H1 2023. Despite this, the gross profit margin remained stable at 57.5%. The decrease in revenue was attributed to global luxury market softness, particularly in EMEA and Greater China, and integration issues with Wolford's new logistics provider.
Lanvin saw 9% growth in APAC excluding Greater China. Strategic actions include...
$SaverOne 2014 (SVRE.US)$
$Apollomics (APLM.US)$
$Alpine Summit Energy Partners (ALPSQ.US)$
$Mangoceuticals (MGRX.US)$
$Advanced Health Intelligence (AHI.US)$
$Lanvin Group (LANV.US)$
$HeartSciences (HSCS.US)$
$Mobilicom (MOB.US)$
$Trxade Health (MEDS.US)$
$Gorilla Technology (GRRR.US)$
$OKYO Pharma (OKYO.US)$
$Cadrenal Therapeutics (CVKD.US)$
$BullFrog AI (BFRG.US)$
$VCI Global (VCIG.US)$